Isabelle Thierry-Chef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Isabelle Thierry-Chef has a total of 504 co-authors. Here are the top co-authors by number of shared publications:
Elisabeth Cardis
Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain
16 shared publications- Dominique Laurier
Health Department, Institute for Radioprotection and Nuclear Safety, Fontenay-aux-Roses, France; s:;
12 shared publications - Mary K. Schubauer-Berigan
International Agency for Research on Cancer (IARC), Lyon, France
12 shared publications Ausrele Kesminiene
International Agency for Research on Cancer, Lyon, France
11 shared publicationsMonika Moissonnier
International Agency for Research on Cancer, Lyon, France
11 shared publications- Robert Douglas Daniels
Division of Science Integration, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA
10 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Oxford University Press (OUP) in Carcinogenesis
Exploring potential associations between low-dose cardiac catheterization radiation and blood microRNA changes in children with congenital heart disease
The risk of cancer from medical exposure to ionizing radiation (IR) in pediatric patients—particularly those with congenital heart disease (CHD)—is a concern, given the need for repeated X-ray-guided cardiac catheterization (CC) procedures throughout their lives. To better understand the effects of low-dose IR, this study—part of the European HARMONIC project—investigated changes in blood miRNA expression following CC in CHD patients. Small RNA sequencing was performed on a discovery cohort of 10 CHD patients at three time points: before CC (T0), immediately after (T1), and one year later (T2). Differentially expressed miRNAs were validated in an independent group of 15 patients using qRT-PCR. KEGG pathway annotation analysis was carried out to determine the biological pathways involving target genes regulated by the dysregulated miRNAs. At the discovery stage, 74 miRNAs were significantly differentially expressed between the T1 and T0 groups, 69 between the T2 and T0 groups, and 41 between the T2 and T1 groups (q-value < 0.05 and |log2(fold change)|>1). Sixteen miRNAs (9 up-regulated and 7 down-regulated) were found dysregulated in both T1 and T2 compared to T0. Additionally, seven known miRNAs were uniquely dysregulated at T2. qRT-PCR analysis of six selected miRNAs partially validated the sequencing results, confirming consistent expression patterns for four miRNAs across cohorts. Pathway enrichment analysis indicated that predicted miRNA target genes were overrepresented in several pathways, including those annotated as cancer-related (enrichment p<0.0001). These findings suggest potential associations with radiation exposure, but their biological significance and health implications remain uncertain and require further investigation.
- 25 May 2026
- Published by Oxford University Press (OUP) in Carcinogenesis
Open AccessExploring potential associations between low-dose cardiac catheterization radiation and blood microRNA changes in children with congenital heart disease
The risk of cancer from medical exposure to ionizing radiation (IR) in pediatric patients—particularly those with congenital heart disease (CHD)—is a concern, given the need for repeated X-ray-guided cardiac catheterization (CC) procedures throughout their lives. To better understand the effects of low-dose IR, this study—part of the European HARMONIC project—investigated changes in blood miRNA expression following CC in CHD patients. Small RNA sequencing was performed on a discovery cohort of 10 CHD patients at three time points: before CC (T0), immediately after (T1), and one year later (T2). Differentially expressed miRNAs were validated in an independent group of 15 patients using qRT-PCR. KEGG pathway annotation analysis was carried out to determine the biological pathways involving target genes regulated by the dysregulated miRNAs. At the discovery stage, 74 miRNAs were significantly differentially expressed between the T1 and T0 groups, 69 between the T2 and T0 groups, and 41 between the T2 and T1 groups (q-value < 0.05 and |log2(fold change)|>1). Sixteen miRNAs (9 up-regulated and 7 down-regulated) were found dysregulated in both T1 and T2 compared to T0. Additionally, seven known miRNAs were uniquely dysregulated at T2. qRT-PCR analysis of six selected miRNAs partially validated the sequencing results, confirming consistent expression patterns for four miRNAs across cohorts. Pathway enrichment analysis indicated that predicted miRNA target genes were overrepresented in several pathways, including those annotated as cancer-related (enrichment p<0.0001). These findings suggest potential associations with radiation exposure, but their biological significance and health implications remain uncertain and require further investigation.
- 27 April 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (2)
Exposure and impact: Highlights from the second scientific conference and recent activities of the International Society for Radiation Epidemiology and Dosimetry (ISoRED)
The International Society for Radiation Epidemiology and Dosimetry (ISoRED) held its second scientific conference on 9–11 September 2025 in Lyon, France, hosted by the International Agency for Research on Cancer. The meeting brought together a multidisciplinary community of researchers to present recent advances in radiation epidemiology, dosimetry, and risk modelling, while fostering international collaboration and supporting early career investigators. The hybrid format enabled broad global participation, with attendees from 16 countries representing academic, governmental, and clinical institutions. This article summarises key scientific, professional, and social highlights of the conference and provides an update on recent activities of the society. The conference programme and a compilation of abstracts are included in the supplementary material.
- 27 April 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (2)
Exposure and impact: Highlights from the second scientific conference and recent activities of the International Society for Radiation Epidemiology and Dosimetry (ISoRED)
The International Society for Radiation Epidemiology and Dosimetry (ISoRED) held its second scientific conference on 9–11 September 2025 in Lyon, France, hosted by the International Agency for Research on Cancer. The meeting brought together a multidisciplinary community of researchers to present recent advances in radiation epidemiology, dosimetry, and risk modelling, while fostering international collaboration and supporting early career investigators. The hybrid format enabled broad global participation, with attendees from 16 countries representing academic, governmental, and clinical institutions. This article summarises key scientific, professional, and social highlights of the conference and provides an update on recent activities of the society. The conference programme and a compilation of abstracts are included in the supplementary material.
- Open Access
- 3 March 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (2)
HARMONIC organ dose calculation framework for cardiac fluoroscopy
The HARMONIC study (health effects of cardiac fluoroscopy and modern radiotherapy in paediatrics) aims, among other objectives, to investigate the relationship between ionising radiation and cancer incidence in children treated by cardiac fluoroscopy procedures (HARMONIC-Cardio). This requires estimation of organ doses for a large patient cohort. A framework for accurate dose calculation was developed, and used to create a software tool for rapid dose estimates. Organ doses were calculated with MCNP6.2 Monte Carlo particle transport code. Eight realistic, anthropomorphic phantoms were used representing newborn, 1, 5, 10, 15 year old and adult patients. Only male phantoms were used for patients younger than 15; male and female for older patients). A large range of technical parameters was covered in the simulations, including 11 primary beam angles and seven secondary angles, four levels of beam filtration, three tube voltages and three field sizes. The absorbed dose was computed for 32 organs and tissues. The calculated organ doses were normalised to the air kerma-area product (PKA), a common modality-specific dose index, resulting in PKA-to-organ-dose conversion coefficients. These coefficients were extended by interpolation. Organ dose conversion coefficients were calculated for 22,176 exposure configurations and interpolated to a total of 2,667,600. The coefficients for 15 organs of interest for radiation protection and effective dose were embedded in HARMONIC-CardioDose: a software tool that enables users to estimate organ doses for virtually any exposure scenario within the simulation range. The program is in the form of a Python script or an executable file, and uses a simple Excel document for inputting technical parameters necessary for calculations. HARMONIC-CardioDose is a validated software tool for rapid estimate of organ doses for paediatric and adult patients undergoing interventional cardiology procedures. The tool is freely available to the medical and research community for supporting patient dosimetry
- 3 March 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (2)
Open AccessHARMONIC organ dose calculation framework for cardiac fluoroscopy
The HARMONIC study (health effects of cardiac fluoroscopy and modern radiotherapy in paediatrics) aims, among other objectives, to investigate the relationship between ionising radiation and cancer incidence in children treated by cardiac fluoroscopy procedures (HARMONIC-Cardio). This requires estimation of organ doses for a large patient cohort. A framework for accurate dose calculation was developed, and used to create a software tool for rapid dose estimates. Organ doses were calculated with MCNP6.2 Monte Carlo particle transport code. Eight realistic, anthropomorphic phantoms were used representing newborn, 1, 5, 10, 15 year old and adult patients. Only male phantoms were used for patients younger than 15; male and female for older patients). A large range of technical parameters was covered in the simulations, including 11 primary beam angles and seven secondary angles, four levels of beam filtration, three tube voltages and three field sizes. The absorbed dose was computed for 32 organs and tissues. The calculated organ doses were normalised to the air kerma-area product (PKA), a common modality-specific dose index, resulting in PKA-to-organ-dose conversion coefficients. These coefficients were extended by interpolation. Organ dose conversion coefficients were calculated for 22,176 exposure configurations and interpolated to a total of 2,667,600. The coefficients for 15 organs of interest for radiation protection and effective dose were embedded in HARMONIC-CardioDose: a software tool that enables users to estimate organ doses for virtually any exposure scenario within the simulation range. The program is in the form of a Python script or an executable file, and uses a simple Excel document for inputting technical parameters necessary for calculations. HARMONIC-CardioDose is a validated software tool for rapid estimate of organ doses for paediatric and adult patients undergoing interventional cardiology procedures. The tool is freely available to the medical and research community for supporting patient dosimetry
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
Supplementary Table from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
Supplementary Table from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
Moderate to high doses of ionizing radiation (IR) are known to increase the risk of cancer, particularly following childhood exposure. Concerns remain regarding risks from lower doses and the role of cancer-predisposing factors (CPF; genetic disorders, immunodeficiency, mutations/variants in DNA damage detection or repair genes) on radiation-induced cancer (RIC) risk. We conducted a systematic review of evidence that CPFs modify RIC risk in young people. Searches were performed in PubMed, Scopus, Web of Science, and EMBASE for epidemiologic studies of cancer risk in humans (<25 years) with a CPF, exposed to low–moderate IR. Risk of bias was considered. Fifteen articles focusing on leukemia, lymphoma, breast, brain, and thyroid cancers were included. We found inadequate evidence that CPFs modify the risk of radiation-induced leukemia, lymphoma, brain/central nervous system, and thyroid cancers and limited evidence that BRCA mutations modify radiation-induced breast cancer risk. Heterogeneity was observed across studies regarding exposure measures, and the numbers of subjects with CPFs other than BRCA mutations were very small. Further studies with more appropriate study designs are needed to elucidate the impact of CPFs on RIC. They should focus either on populations of carriers of specific gene mutations or on common susceptible variants using polygenic risk scores.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review
Moderate to high doses of ionizing radiation (IR) are known to increase the risk of cancer, particularly following childhood exposure. Concerns remain regarding risks from lower doses and the role of cancer-predisposing factors (CPF; genetic disorders, immunodeficiency, mutations/variants in DNA damage detection or repair genes) on radiation-induced cancer (RIC) risk. We conducted a systematic review of evidence that CPFs modify RIC risk in young people. Searches were performed in PubMed, Scopus, Web of Science, and EMBASE for epidemiologic studies of cancer risk in humans (<25 years) with a CPF, exposed to low–moderate IR. Risk of bias was considered. Fifteen articles focusing on leukemia, lymphoma, breast, brain, and thyroid cancers were included. We found inadequate evidence that CPFs modify the risk of radiation-induced leukemia, lymphoma, brain/central nervous system, and thyroid cancers and limited evidence that BRCA mutations modify radiation-induced breast cancer risk. Heterogeneity was observed across studies regarding exposure measures, and the numbers of subjects with CPFs other than BRCA mutations were very small. Further studies with more appropriate study designs are needed to elucidate the impact of CPFs on RIC. They should focus either on populations of carriers of specific gene mutations or on common susceptible variants using polygenic risk scores.
- Open Access
- 17 November 2025
- Published by Queen's University Library in POCUS Journal
- Vol. 10 (02) , 123-134
POCUS Examination of the Mediastinum in Children: A Simplified and Standardized Protocol for Pulmonary Tuberculosis
Background: Point of care ultrasound (POCUS) is increasingly recognized as a valuable tool for mediastinal assessment in children, particularly in resource-limited settings where advanced radiological options such as computed tomography (CT) scans are often unavailable. In high-income countries, POCUS is gaining traction as a complementary imaging method, offering a safer, radiation-free alternative. Methods: To overcome the operator-dependent nature of mediastinal POCUS, a standardized protocol was developed. The protocol includes clear techniques and detailed descriptions of normal and pathological findings, aiming to enhance consistency and diagnostic accuracy. Results: The standardized protocol improved reliability in mediastinal POCUS assessments, especially in the context of paediatric pulmonary tuberculosis, a condition often marked by lymph node involvement. Given the challenges of obtaining respiratory samples in children and their typically low diagnostic yield, POCUS emerged as a particularly suitable diagnostic modality. Conclusions: Mediastinal POCUS, guided by a standardized protocol, represents a safe, affordable, point-of-care, and non-ionizing option for identifying mediastinal lymphadenopathy. Its application holds promise for improving the diagnosis of paediatric tuberculosis, especially in settings with limited access to advanced radiological imaging
- 17 November 2025
- Published by Queen's University Library in POCUS Journal
- Vol. 10 (02) , 123-134
Open AccessPOCUS Examination of the Mediastinum in Children: A Simplified and Standardized Protocol for Pulmonary Tuberculosis
Background: Point of care ultrasound (POCUS) is increasingly recognized as a valuable tool for mediastinal assessment in children, particularly in resource-limited settings where advanced radiological options such as computed tomography (CT) scans are often unavailable. In high-income countries, POCUS is gaining traction as a complementary imaging method, offering a safer, radiation-free alternative. Methods: To overcome the operator-dependent nature of mediastinal POCUS, a standardized protocol was developed. The protocol includes clear techniques and detailed descriptions of normal and pathological findings, aiming to enhance consistency and diagnostic accuracy. Results: The standardized protocol improved reliability in mediastinal POCUS assessments, especially in the context of paediatric pulmonary tuberculosis, a condition often marked by lymph node involvement. Given the challenges of obtaining respiratory samples in children and their typically low diagnostic yield, POCUS emerged as a particularly suitable diagnostic modality. Conclusions: Mediastinal POCUS, guided by a standardized protocol, represents a safe, affordable, point-of-care, and non-ionizing option for identifying mediastinal lymphadenopathy. Its application holds promise for improving the diagnosis of paediatric tuberculosis, especially in settings with limited access to advanced radiological imaging
- Open Access
Addressing Akrasia in Childhood, Adolescent and Young Adult Cancer Survivors: Implications for Long-Term Follow-Up and Preventive Health Interventions
Background: Childhood, adolescent, and young adult cancer survivors (CAYACS) face significant long-term health risks, yet adherence to long-term follow-up (LTFU) care remains inconsistent. This study explores the concept of akrasia (i.e., acting against one’s better judgment by engaging in behaviors known to be harmful or counterproductive) to understand the psychological, cognitive, and systemic barriers influencing survivor engagement in LTFU. Method: Using an ethical reflection approach based on a literature review, we discussed survivor experiences, behavioral science insights, and ethical principles to identify solutions that balance patient autonomy with supportive interventions. A narrative approach was used to summarize the key points discussed during the ethics reflection group meetings. Results: Our findings highlight key barriers such as trauma, avoidance behaviors, and cognitive constraints that contribute to non-adherence. Strategies such as shared decision-making, digital health tools, and nudge-based interventions are proposed to enhance survivor engagement. Ethical considerations emphasize the need for personalized and flexible care approaches that respect survivor agency while mitigating obstacles to adherence. Conclusions: Addressing akrasia through ethical and behavioral frameworks could improve LTFU adherence, ultimately enhancing survivorship care and long-term health outcomes.
Open AccessAddressing Akrasia in Childhood, Adolescent and Young Adult Cancer Survivors: Implications for Long-Term Follow-Up and Preventive Health Interventions
Background: Childhood, adolescent, and young adult cancer survivors (CAYACS) face significant long-term health risks, yet adherence to long-term follow-up (LTFU) care remains inconsistent. This study explores the concept of akrasia (i.e., acting against one’s better judgment by engaging in behaviors known to be harmful or counterproductive) to understand the psychological, cognitive, and systemic barriers influencing survivor engagement in LTFU. Method: Using an ethical reflection approach based on a literature review, we discussed survivor experiences, behavioral science insights, and ethical principles to identify solutions that balance patient autonomy with supportive interventions. A narrative approach was used to summarize the key points discussed during the ethics reflection group meetings. Results: Our findings highlight key barriers such as trauma, avoidance behaviors, and cognitive constraints that contribute to non-adherence. Strategies such as shared decision-making, digital health tools, and nudge-based interventions are proposed to enhance survivor engagement. Ethical considerations emphasize the need for personalized and flexible care approaches that respect survivor agency while mitigating obstacles to adherence. Conclusions: Addressing akrasia through ethical and behavioral frameworks could improve LTFU adherence, ultimately enhancing survivorship care and long-term health outcomes.
- 1 September 2024
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 44 (3) , 036001
The international society for radiation epidemiology and dosimetry (ISoRED)
- 1 September 2024
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 44 (3) , 036001
The international society for radiation epidemiology and dosimetry (ISoRED)
- Open Access
- 18 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0299293
Evaluation of radiological capacity and usage in paediatric TB diagnosis: A mixed-method protocol of a comparative study in Mozambique, South Africa and Spain
Introduction: Tuberculosis remains one of the top ten causes of mortality globally. Children accounted for 12% of all TB cases and 18% of all TB deaths in 2022. Paediatric TB is difficult to diagnose with conventional laboratory tests, and chest radiographs remain crucial. However, in low-and middle-income countries with high TB burden, the capacity for radiological diagnosis of paediatric TB is rarely documented and data on the associated radiation exposure limited. Methods: A multicentre, mixed-methods study is proposed in three countries, Mozambique, South Africa and Spain. At the national level, official registry databases will be utilised to retrospectively compile an inventory of licensed imaging resources (mainly X-ray and Computed Tomography (CT) scan equipment) for the year 2021. At the selected health facility level, three descriptive cross-sectional standardised surveys will be conducted to assess radiology capacity, radiological imaging diagnostic use for paediatric TB diagnosis, and radiation protection optimization: a site survey, a clinician-targeted survey, and a radiology staff-targeted survey, respectively. At the patient level, potential dose optimisation will be assessed for children under 16 years of age who were diagnosed and treated for TB in selected sites in each country. For this component, a retrospective analysis of dosimetry will be performed on TB and radiology data routinely collected at the respective sites. National inventory data will be presented as the number of units per million people by modality, region and country. Descriptive analyses will be conducted on survey data, including the demographic, clinical and programmatic characteristics of children treated for TB who had imaging examinations (chest X-ray (CXR) and/or CT scan). Dose exposure analysis will be performed by children’s age, gender and disease spectrum. Discussion: As far as we know, this is the first multicentre and multi-national study to compare radiological capacity, radiation protection optimization and practices between high and low TB burden settings in the context of childhood TB management. The planned comparative analyses will inform policy-makers of existing radiological capacity and deficiencies, allowing better resource prioritisation. It will inform clinicians and radiologists on best practices and means to optimise the use of radiological technology in paediatric TB management.
- 18 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0299293
Open AccessEvaluation of radiological capacity and usage in paediatric TB diagnosis: A mixed-method protocol of a comparative study in Mozambique, South Africa and Spain
Introduction: Tuberculosis remains one of the top ten causes of mortality globally. Children accounted for 12% of all TB cases and 18% of all TB deaths in 2022. Paediatric TB is difficult to diagnose with conventional laboratory tests, and chest radiographs remain crucial. However, in low-and middle-income countries with high TB burden, the capacity for radiological diagnosis of paediatric TB is rarely documented and data on the associated radiation exposure limited. Methods: A multicentre, mixed-methods study is proposed in three countries, Mozambique, South Africa and Spain. At the national level, official registry databases will be utilised to retrospectively compile an inventory of licensed imaging resources (mainly X-ray and Computed Tomography (CT) scan equipment) for the year 2021. At the selected health facility level, three descriptive cross-sectional standardised surveys will be conducted to assess radiology capacity, radiological imaging diagnostic use for paediatric TB diagnosis, and radiation protection optimization: a site survey, a clinician-targeted survey, and a radiology staff-targeted survey, respectively. At the patient level, potential dose optimisation will be assessed for children under 16 years of age who were diagnosed and treated for TB in selected sites in each country. For this component, a retrospective analysis of dosimetry will be performed on TB and radiology data routinely collected at the respective sites. National inventory data will be presented as the number of units per million people by modality, region and country. Descriptive analyses will be conducted on survey data, including the demographic, clinical and programmatic characteristics of children treated for TB who had imaging examinations (chest X-ray (CXR) and/or CT scan). Dose exposure analysis will be performed by children’s age, gender and disease spectrum. Discussion: As far as we know, this is the first multicentre and multi-national study to compare radiological capacity, radiation protection optimization and practices between high and low TB burden settings in the context of childhood TB management. The planned comparative analyses will inform policy-makers of existing radiological capacity and deficiencies, allowing better resource prioritisation. It will inform clinicians and radiologists on best practices and means to optimise the use of radiological technology in paediatric TB management.
- Open Access
- 24 May 2023
- Published by EDP Sciences in EPJ Nuclear Sciences & Technologies
- Vol. 9, 22
Health effects of ionising radiation in paediatrics undergoing either cardiac fluoroscopy or modern radiotherapy (The HARMONIC project)
The use of ionising radiation (IR) for medical diagnosis and treatment procedures has had a major impact on the survival of paediatric patients. Although the benefits of these techniques lead to efficient health care, evaluation of potential associated long-term health effects is required. HARMONIC aims to better understand the increased risk of cancer and non-cancer effects after exposure to medical IR in children with cancer treated with modern external beam radiotherapy (EBRT) – radiation energy in MeV range – and in children with cardiac defects diagnosed and treated with cardiac fluoroscopy procedures (CFP) – radiation energy in keV range. The project investigates, among survivors of paediatric cancer, potential endocrine dysfunction, cardiovascular and neurovascular damage, health-related quality of life and second (and subsequent) primary cancer (SPC). The cardiac component builds a pooled cohort of approximately 90 000 paediatric patients who underwent CFP during childhood and adolescence to investigate cancer risk following exposure to IR and explore the potential effects of conditions predisposing to cancer. HARMONIC develops software tools to allow dose reconstruction in both EBRT and CFP to enable epidemiological investigations and future optimisation of treatments. With the creation of a biobank of blood and saliva samples, HARMONIC aims to provide a mechanistic understanding of radiation-induced adverse health effects and identify potential biomarkers that can predict these effects.
- 24 May 2023
- Published by EDP Sciences in EPJ Nuclear Sciences & Technologies
- Vol. 9, 22
Open AccessHealth effects of ionising radiation in paediatrics undergoing either cardiac fluoroscopy or modern radiotherapy (The HARMONIC project)
The use of ionising radiation (IR) for medical diagnosis and treatment procedures has had a major impact on the survival of paediatric patients. Although the benefits of these techniques lead to efficient health care, evaluation of potential associated long-term health effects is required. HARMONIC aims to better understand the increased risk of cancer and non-cancer effects after exposure to medical IR in children with cancer treated with modern external beam radiotherapy (EBRT) – radiation energy in MeV range – and in children with cardiac defects diagnosed and treated with cardiac fluoroscopy procedures (CFP) – radiation energy in keV range. The project investigates, among survivors of paediatric cancer, potential endocrine dysfunction, cardiovascular and neurovascular damage, health-related quality of life and second (and subsequent) primary cancer (SPC). The cardiac component builds a pooled cohort of approximately 90 000 paediatric patients who underwent CFP during childhood and adolescence to investigate cancer risk following exposure to IR and explore the potential effects of conditions predisposing to cancer. HARMONIC develops software tools to allow dose reconstruction in both EBRT and CFP to enable epidemiological investigations and future optimisation of treatments. With the creation of a biobank of blood and saliva samples, HARMONIC aims to provide a mechanistic understanding of radiation-induced adverse health effects and identify potential biomarkers that can predict these effects.